Neurosense Therapeutics Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.45

+0.01 (+2.26%)

As of Aug 15, 2:29 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +7,675.3% upside

Low Target $27.84

Average Target $35.23

High Target $57.14

Current Price $0.45

Current
$0.45

Target
$35.23

$27.84 $35.23 avg $57.14

Scenario Analysis

Bear Case

$27.84

6,044.3%

Low target

Base Case

$35.23

+7,675.3%

Avg target

Bull Case

$57.14

+12,510.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$1.98

-77.1% from high

52-Week Low

$0.39

+15.3% from low

Target vs 52W High

$35.23

+1,679.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%